Results 341 to 350 of about 5,184,059 (400)

Corrigendum: Insights into vitamin A in bladder cancer, lack of attention to gut microbiota? [PDF]

Front Immunol
Luo P, Zheng L, Zou J, Chen T, Zou J, Li W, Chen Q, Qian B.   +7 more
europepmc   +1 more source

RETRACTION: KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo. [PDF]

Dis Markers
Markers D.
europepmc   +1 more source

Integrative Analysis Reveals the Prognostic Effects of Epigenetic Regulators in Bladder Cancer. [PDF]

Cancer Med
Mekala V, Lin Y, Wang X, Chowdhury N, Li J, Cheng C.   +5 more
europepmc   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Bladder cancer accounts for nearly 170,000 deaths worldwide annually. For over 4 decades, the systemic management of muscle‐invasive and advanced bladder cancer has primarily consisted of platinum‐based chemotherapy.
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly   +2 more sources

The role of the HIF‐1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer

Cancer Communications, 2021
As a rate‐limiting enzyme of glycolysis, pyruvate kinase muscle isozyme M2 (PKM2) participates in tumor metabolism and growth. The regulatory network of PKM2 in cancer is complex and has not been fully studied in bladder cancer. The 5‐methylcytidine (m5C)
Qiang Lu, Ji-fu Wei, Haiwei Yang
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Radiotherapy With or Without Chemotherapy in Muscle-Invasive Bladder Cancer

50 Studies Every Urologist Should Know, 2021
This randomized study assessed the role of synchronous chemotherapy with intravenous 5-fluorouracil and mitomycin in patients with muscle-invasive bladder cancer undergoing radiotherapy compared to radiotherapy only.
V. Narayan
semanticscholar   +1 more source